Digestive & Intestinal Remedies (Pharmacies) - Iraq

  • Iraq
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$59.44m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.63%, resulting in a market volume of US$64.44m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.28 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Iraq is experiencing steady growth due to customer preferences for over-the-counter remedies, increasing awareness about digestive health, and the local special circumstances in the country. Customer preferences in Iraq play a significant role in the development of the Digestive & Intestinal Remedies market. Many consumers prefer to self-medicate and seek immediate relief from common digestive issues such as indigestion, heartburn, and stomach pain. This preference for over-the-counter remedies has led to a rise in the demand for Digestive & Intestinal Remedies in pharmacies across the country. Additionally, consumers are increasingly looking for natural and herbal remedies to address their digestive health concerns, further driving the market growth. Trends in the Digestive & Intestinal Remedies market in Iraq are aligned with global and regional market trends. There is a growing awareness among consumers about the importance of maintaining a healthy digestive system. This awareness is fueled by the increasing prevalence of digestive disorders and the promotion of healthy lifestyles by healthcare professionals. As a result, there is a rising demand for Digestive & Intestinal Remedies that offer long-term relief and promote overall digestive health. Manufacturers are responding to this trend by introducing innovative products with natural ingredients and enhanced efficacy. Local special circumstances in Iraq also contribute to the development of the Digestive & Intestinal Remedies market. The country has a high prevalence of gastrointestinal disorders, including irritable bowel syndrome, gastroesophageal reflux disease, and peptic ulcers. These conditions require long-term management and often necessitate the use of Digestive & Intestinal Remedies. Additionally, the consumption of spicy and oily food is common in the Iraqi diet, which can lead to digestive issues. This cultural factor further drives the demand for Digestive & Intestinal Remedies in the country. Underlying macroeconomic factors also play a role in the growth of the Digestive & Intestinal Remedies market in Iraq. The country has a large and growing population, which translates into a significant consumer base for healthcare products. Furthermore, the improving economic conditions and rising disposable incomes have increased the affordability of Digestive & Intestinal Remedies for many Iraqis. This, coupled with the increasing availability of these products in pharmacies, has contributed to the market's expansion. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Iraq is developing due to customer preferences for over-the-counter remedies, increasing awareness about digestive health, local special circumstances, and underlying macroeconomic factors. As consumers continue to prioritize their digestive well-being, the market is expected to witness further growth in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)